Insider Transactions in Q1 2024 at Hims & Hers Health, Inc. (HIMS)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2024
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,972
+3.59%
|
$11,944
$2.43 P/Share
|
|
Feb 14
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
17,109
-9.98%
|
$171,090
$10.0 P/Share
|
|
Feb 14
2024
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,109
+9.07%
|
$34,218
$2.43 P/Share
|
|
Feb 14
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
77,382
-59.97%
|
$696,438
$9.9 P/Share
|
|
Feb 14
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
77,382
+37.49%
|
$154,764
$2.43 P/Share
|
|
Feb 13
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
97,208
-65.3%
|
$874,872
$9.58 P/Share
|
|
Feb 13
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
97,208
+39.5%
|
$194,416
$2.43 P/Share
|
|
Feb 12
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
81,541
-61.22%
|
$733,869
$9.98 P/Share
|
|
Feb 12
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
81,541
+37.97%
|
$163,082
$2.43 P/Share
|
|
Feb 12
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
31,363
-16.68%
|
$313,630
$10.03 P/Share
|
|
Feb 12
2024
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,385
+12.3%
|
$131,925
$5.01 P/Share
|
|
Feb 12
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
22,839
-12.89%
|
$228,390
$10.03 P/Share
|
|
Feb 12
2024
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,839
+11.42%
|
$45,678
$2.43 P/Share
|
|
Feb 09
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,509
-5.0%
|
$85,090
$10.03 P/Share
|
|
Feb 09
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,080
-2.58%
|
$40,800
$10.03 P/Share
|
|
Feb 09
2024
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,080
+2.51%
|
$8,160
$2.43 P/Share
|
|
Jan 29
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,100
-22.62%
|
$135,900
$9.01 P/Share
|
|
Jan 29
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,100
+18.45%
|
$30,200
$2.43 P/Share
|
|
Jan 26
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
52,940
-50.62%
|
$476,460
$9.11 P/Share
|
|
Jan 26
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
52,940
+33.61%
|
$105,880
$2.43 P/Share
|
|
Jan 25
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
127,688
-71.2%
|
$1,149,192
$9.08 P/Share
|
|
Jan 25
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
127,688
+41.59%
|
$255,376
$2.43 P/Share
|
|
Jan 02
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
13,744
-8.18%
|
$109,952
$8.8 P/Share
|